Your browser doesn't support javascript.
loading
Analysis of glucocerebrosidase (GBA) gene mutations in Iranian patients with Gaucher disease.
Mozafari, Hadi; Tghikhani, Mohammad; Rahimi, Zohreh; Vaisi Raygani, Asad; Ansari, Shahla; Khatami, Shohreh; Alaei, Mohammad Reza; Saghiri, Reza.
Afiliación
  • Mozafari H; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Tghikhani M; Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Rahimi Z; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Vaisi Raygani A; Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Ansari S; Department of Hematology and Oncology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Khatami S; Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran.
  • Alaei MR; Department of Pediatrics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Saghiri R; Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran.
Iran J Child Neurol ; 15(3): 139-166, 2021.
Article en En | MEDLINE | ID: mdl-34282371
ABSTRACT

OBJECTIVES:

Gaucher disease (GD) is the most common autosomal recessive disorder of glycolipid storage. It results from mutations in the glucocerebrosidase (GBA) gene and leads to GBA deficiency. Different mutations are associated with different phenotypes in the three major types of GD. MATERIALS AND

METHODS:

The spectrum of mutations in GBA gene in 26 unrelated patients with GD from different Iranian populations was determined by DNA sequencing, polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP), and amplification-refractory mutation system (ARMS) methods. An in silico analysis was also performed for novel mutations.

RESULTS:

Six new mutations were identified in this study. The newly detected mutations that could be theoretically harmful included p.I200T (c.599T>C), p.H312D (c.934C>G), p.L325S (c.974T>C), p.L393V (c.1177C>G), p.S439G (c.1315A>G), and p.M455R (c.1365G>A). Also, p.L483P, p.N409S, p.W420X, p.E379K, p.R398Q, p.N227S, p.R202Q, and p.D448H mutations were identified in the patients. Besides, two new complex mutations, namely, p.S439G/p.S439G+p.E379K/- and p.R202Q/p.R202Q+p.N227S/p.N227S, were detected. The most common GBA mutation in the population was p.L483P with an allele frequency of 32.7%, followed by p.N409S (19.2%).

CONCLUSION:

The present study detected six new mutations of GBA gene among GD patients. Two mutations (p.L483P and p.N409S) were especially common among Iranians; this finding can be used in implementing screening programs and understanding the molecular basis of GD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Iran J Child Neurol Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Iran J Child Neurol Año: 2021 Tipo del documento: Article País de afiliación: Irán